These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 25324357

  • 1. Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar; 30(3):434-40. PubMed ID: 25324357
    [Abstract] [Full Text] [Related]

  • 2. The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease.
    Arcidiacono MV, Yang J, Fernandez E, Dusso A.
    Nephrol Dial Transplant; 2015 Mar; 30(3):423-33. PubMed ID: 25294851
    [Abstract] [Full Text] [Related]

  • 3. NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.
    Kan S, Zhang W, Mao J, Wang M, Ni L, Zhang M, Zhang Q, Chen J.
    J Nephrol; 2018 Dec; 31(6):941-951. PubMed ID: 30171599
    [Abstract] [Full Text] [Related]

  • 4. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
    Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J.
    Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.
    Naveh-Many T, Volovelsky O.
    Int J Mol Sci; 2020 Jun 18; 21(12):. PubMed ID: 32570711
    [Abstract] [Full Text] [Related]

  • 6. EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease.
    Arcidiacono MV, Sato T, Alvarez-Hernandez D, Yang J, Tokumoto M, Gonzalez-Suarez I, Lu Y, Tominaga Y, Cannata-Andia J, Slatopolsky E, Dusso AS.
    J Am Soc Nephrol; 2008 Feb 18; 19(2):310-20. PubMed ID: 18216322
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Feb 18; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 8. Influence of parathyroid mass on the regulation of PTH secretion.
    Lewin E, Olgaard K.
    Kidney Int Suppl; 2006 Jul 18; (102):S16-21. PubMed ID: 16810305
    [Abstract] [Full Text] [Related]

  • 9. Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.
    Arcidiacono MV, Cozzolino M, Spiegel N, Tokumoto M, Yang J, Lu Y, Sato T, Lomonte C, Basile C, Slatopolsky E, Dusso AS.
    J Am Soc Nephrol; 2008 Oct 18; 19(10):1919-28. PubMed ID: 18579641
    [Abstract] [Full Text] [Related]

  • 10. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A, Canalejo R, Rodriguez ME, Martinez-Moreno JM, Felsenfeld AJ, Rodríguez M, Almaden Y.
    Nephrol Dial Transplant; 2010 Apr 18; 25(4):1087-97. PubMed ID: 19934096
    [Abstract] [Full Text] [Related]

  • 11. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz-Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M.
    J Am Soc Nephrol; 2010 Jul 18; 21(7):1125-35. PubMed ID: 20431039
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor and analogs.
    Dusso AS, Thadhani R, Slatopolsky E.
    Semin Nephrol; 2004 Jan 18; 24(1):10-6. PubMed ID: 14730505
    [Abstract] [Full Text] [Related]

  • 13. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
    Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM.
    Nephrol Dial Transplant; 2012 Jun 18; 27(6):2198-205. PubMed ID: 22036941
    [Abstract] [Full Text] [Related]

  • 14. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.
    Slatopolsky E, Brown A, Dusso A.
    Am J Kidney Dis; 2001 Jan 18; 37(1 Suppl 2):S54-7. PubMed ID: 11158862
    [Abstract] [Full Text] [Related]

  • 15. miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.
    Xu M, Li H, Bai Y, He J, Chen R, An N, Li Y, Dong Y.
    Am J Med Sci; 2021 May 18; 361(5):624-634. PubMed ID: 33781552
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
    Shiizaki K, Negi S, Hatamura I, Sakaguchi T, Saji F, Kunimoto K, Mizobuchi M, Imazeki I, Ooshima A, Akizawa T.
    J Am Soc Nephrol; 2005 Jan 18; 16(1):97-108. PubMed ID: 15574509
    [Abstract] [Full Text] [Related]

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 18; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 18. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB.
    Endocrinology; 2012 Apr 18; 153(4):1627-37. PubMed ID: 22334717
    [Abstract] [Full Text] [Related]

  • 19. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
    Shiizaki K, Hatamura I, Nakazawa E, Ogura M, Masuda T, Akizawa T, Kusano E.
    Med Mol Morphol; 2008 Jun 18; 41(2):76-82. PubMed ID: 18592161
    [Abstract] [Full Text] [Related]

  • 20. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
    Henley C, Davis J, Miller G, Shatzen E, Cattley R, Li X, Martin D, Yao W, Lane N, Shalhoub V.
    Eur J Pharmacol; 2009 Aug 15; 616(1-3):306-13. PubMed ID: 19470383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.